Literature DB >> 8391697

A structure-activity relationship study of batracylin analogues.

Y Luo1, Y F Ren, T C Chou, A Y Chen, C Yu, L F Liu, C C Cheng.   

Abstract

A number of isoindolo[1,2-b]quinazolines and some benzo[4,5]isoquinolino[1,2-b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methylenedioxyisoindolo[1,2-b]quinazolin-1 2(10H)-one (1d), 2-amino-10,12-dihydroisoindolo[1,2-b]quinazolin-12(10H)-one (1p), and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[1,2-b] quinazolin-12(10H)-one (1ab) exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391697     DOI: 10.1023/a:1018929815422

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Activity of batracylin (NSC-320846) against solid tumors of mice.

Authors:  P Mucci-LoRusso; L Polin; M C Bissery; F Valeriote; J Plowman; G D Luk; T H Corbett
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

Review 2.  Structural aspects of antineoplastic agents--a new approach.

Authors:  C C Cheng
Journal:  Prog Med Chem       Date:  1988

3.  Identification of the breakage-reunion subunit of T4 DNA topoisomerase.

Authors:  T C Rowe; K M Tewey; L F Liu
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

4.  Preclinical antitumor activity of batracylin (NSC 320846).

Authors:  J Plowman; K D Paull; G Atassi; S D Harrison; D J Dykes; H J Kabbe; V L Narayanan; O C Yoder
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

5.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

6.  Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

Authors:  B D Halligan; K A Edwards; L F Liu
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

7.  Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat.

Authors:  M M Ames; D A Mathiesen; J M Reid
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

8.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Authors:  K M Tewey; T C Rowe; L Yang; B D Halligan; L F Liu
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

9.  Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.

Authors:  T J Vietti; F A Valeriote; R Kalish; D Coulter
Journal:  Cancer Treat Rep       Date:  1978-09

10.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

View more
  1 in total

1.  Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats.

Authors:  Myrtle Davis; Deborah I Bunin; Steven J Samuelsson; Kenneth P Altera; Robert J Kinders; Scott M Lawrence; Jiuping Ji; Matthew M Ames; Sarah A Buhrow; Chad Walden; Joel M Reid; Linda L Rausch; Toufan Parman
Journal:  Toxicol Pathol       Date:  2014-10-01       Impact factor: 1.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.